Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Ji

Showing results (581-590 of 585) with videos related to

Pageof 59
Sort By:
You have reached the last page of results.This site can display upto 585 results.
The Lancet. Oncology|May 14, 2013
Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trialJie Jin, Jian-Xiang Wang, Fei-Fei Chen, et al.
Blood Advances|April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm studyLi-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 1, 2022
PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1Qian-Zhi Ni, Bing Zhu, Yan Ji, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2021
Identification of Novel Risk Loci for Behçet's Disease-Related Uveitis in a Chinese Population in a Genome-Wide Association StudyGuannan Su, Zhenyu Zhong, Qingyun Zhou, et al.
Annals of Translational Medicine|September 16, 2022
Stroke incidence and cognitive outcomes of intracranial atherosclerotic stenosis: study protocol for a multicenter, prospective, observational cohort studyQianqian Si, Yuming Teng, Caiyan Liu, et al.
Pageof 59

Showing results (581-590 of 585) with videos related to

Sort By:
Pageof 59
You have reached the last page of results.This site can display upto 585 results.
The Lancet. Oncology|May 14, 2013
Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trialJie Jin, Jian-Xiang Wang, Fei-Fei Chen, et al.
Blood Advances|April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm studyLi-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 1, 2022
PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1Qian-Zhi Ni, Bing Zhu, Yan Ji, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2021
Identification of Novel Risk Loci for Behçet's Disease-Related Uveitis in a Chinese Population in a Genome-Wide Association StudyGuannan Su, Zhenyu Zhong, Qingyun Zhou, et al.
Annals of Translational Medicine|September 16, 2022
Stroke incidence and cognitive outcomes of intracranial atherosclerotic stenosis: study protocol for a multicenter, prospective, observational cohort studyQianqian Si, Yuming Teng, Caiyan Liu, et al.
Pageof 59